PMID- 31385389 OWN - NLM STAT- MEDLINE DCOM- 20210616 LR - 20210809 IS - 1440-1843 (Electronic) IS - 1323-7799 (Linking) VI - 25 IP - 3 DP - 2020 Mar TI - Blood eosinophil count as a predictor of hospital length of stay in COPD exacerbations. PG - 259-266 LID - 10.1111/resp.13660 [doi] AB - BACKGROUND AND OBJECTIVE: Airway inflammation accompanying exacerbations varies among individuals with some having neutrophilic, while others showing eosinophilic inflammation. This study assessed the cut-off values of blood eosinophil count for identifying subjects with longer hospital length of stay (LOS) with acute exacerbations of chronic obstructive pulmonary disease (AECOPD). METHODS: Patients were recruited at presentation to the hospital with an AECOPD. Complete blood picture with differential count was taken on admission. Patients were treated with a standard course of systemic corticosteroid and antibiotic and evaluated at 8 weeks post-exacerbation for lung function measurement and 6-min walk. They were followed up in 1 year for any readmissions or mortality. Cut-off values of eosinophils for assessment of longer LOS were calculated using receiver operating characteristic (ROC) curve analysis. RESULTS: A total of 346 patients with admission eosinophil count were included in the analysis (333 (96.2%) were males; mean +/- SD age: 74.9 +/- 7.8 years; mean forced expiratory volume in 1 s (FEV(1) ): 43.4 +/- 16.3% predicted). The median (interquartile range (IQR)) of the absolute peripheral eosinophil count, percent eosinophil count and LOS were 0.11 (0.25) x 10(9) /L, 1 (3) % and 5 (7) days, respectively. Using the median LOS of >/=5 days as the cut-off, ROC analysis of the cut-off value of eosinophil count associated with longer LOS was at <2% (area under the curve (AUC): 0.666, P < 0.001) while absolute eosinophil count was at <0.144 x 10(9) /L (AUC: 0.645, P < 0.001). These eosinophil cut-off values could predict longer LOS independent of age, lung function and previous hospital admissions, but had no association with readmissions for AECOPD and mortality at 12 months. CONCLUSION: An eosinophil value of <0.144 x 10(9) /L on admission or <2% was associated with longer hospital LOS for AECOPD. CI - (c) 2019 Asian Pacific Society of Respirology. FAU - Ko, Fanny W S AU - Ko FWS AUID- ORCID: 0000-0001-8454-0087 AD - SH Ho Research Center in Respiratory Diseases, Division of Respiratory Medicine, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong. FAU - Chan, Ka Pang AU - Chan KP AUID- ORCID: 0000-0002-8163-5846 AD - SH Ho Research Center in Respiratory Diseases, Division of Respiratory Medicine, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong. FAU - Ngai, Jenny AU - Ngai J AD - SH Ho Research Center in Respiratory Diseases, Division of Respiratory Medicine, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong. FAU - Ng, So-Shan AU - Ng SS AD - SH Ho Research Center in Respiratory Diseases, Division of Respiratory Medicine, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong. FAU - Yip, Wing Ho AU - Yip WH AD - SH Ho Research Center in Respiratory Diseases, Division of Respiratory Medicine, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong. FAU - Ip, April AU - Ip A AD - SH Ho Research Center in Respiratory Diseases, Division of Respiratory Medicine, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong. FAU - Chan, Tat-On AU - Chan TO AD - SH Ho Research Center in Respiratory Diseases, Division of Respiratory Medicine, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong. FAU - Hui, David S C AU - Hui DSC AUID- ORCID: 0000-0003-4382-2445 AD - SH Ho Research Center in Respiratory Diseases, Division of Respiratory Medicine, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong. LA - eng SI - ClinicalTrials.gov/NCT02815761 PT - Journal Article DEP - 20190806 PL - Australia TA - Respirology JT - Respirology (Carlton, Vic.) JID - 9616368 SB - IM CIN - Respirology. 2020 Mar;25(3):230-231. PMID: 31468623 CIN - Respirology. 2021 May;26(5):504-506. PMID: 33660367 CIN - Respirology. 2021 May;26(5):504. PMID: 33660387 MH - Aged MH - Aged, 80 and over MH - Area Under Curve MH - *Eosinophils MH - Female MH - Forced Expiratory Volume MH - Humans MH - *Length of Stay MH - Leukocyte Count MH - Male MH - Patient Readmission MH - Pulmonary Disease, Chronic Obstructive/*blood/physiopathology MH - ROC Curve MH - Survival Rate MH - *Symptom Flare Up OTO - NOTNLM OT - airway inflammation OT - chronic obstructive pulmonary disease OT - eosinophils OT - exacerbations EDAT- 2019/08/07 06:00 MHDA- 2021/06/17 06:00 CRDT- 2019/08/07 06:00 PHST- 2018/12/21 00:00 [received] PHST- 2019/05/06 00:00 [revised] PHST- 2019/06/27 00:00 [accepted] PHST- 2019/08/07 06:00 [pubmed] PHST- 2021/06/17 06:00 [medline] PHST- 2019/08/07 06:00 [entrez] AID - 10.1111/resp.13660 [doi] PST - ppublish SO - Respirology. 2020 Mar;25(3):259-266. doi: 10.1111/resp.13660. Epub 2019 Aug 6.